{"id":8226,"date":"2020-06-10T09:19:59","date_gmt":"2020-06-10T14:19:59","guid":{"rendered":"https:\/\/saluddigital.com\/?p=8226"},"modified":"2025-10-21T14:59:57","modified_gmt":"2025-10-21T20:59:57","slug":"oleena-plataforma-autorizada-por-la-fda-para-manejar-sintomas-de-pacientes-con-cancer","status":"publish","type":"post","link":"https:\/\/saluddigital.com\/en\/plataformas-digitales\/oleena-plataforma-autorizada-por-la-fda-para-manejar-sintomas-de-pacientes-con-cancer\/","title":{"rendered":"Oleena: FDA-authorized platform for managing symptoms of cancer patients"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"8226\" class=\"elementor elementor-8226\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-925a2d9 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-equal-height-no\" data-id=\"925a2d9\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-9307616\" data-id=\"9307616\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-4c49d72 elementor-widget elementor-widget-heading\" data-id=\"4c49d72\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Voluntis' patented platform works with algorithms that, based on user information, will provide personalized guidance on cancer symptoms and how to mitigate them. In addition, technical teams will be able to monitor and generate more information regarding the patient's condition.<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-66d92f3 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-equal-height-no\" data-id=\"66d92f3\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-22de540\" data-id=\"22de540\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-d40484c elementor-widget elementor-widget-text-editor\" data-id=\"d40484c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>The <strong>U.S. Food and Drug Administration (FDA)<\/strong> has approved the Oleena platform that, based on algorithms and user experience, will provide personalized patient dynamics as well as monitoring and generating information for healthcare professionals.<\/p><p>Oleena is software that is part of Class II devices, this means that they are of medium risk and do not use medical substances to generate a diagnosis with the patient.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-3f61685 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-equal-height-no\" data-id=\"3f61685\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-0fd0d80\" data-id=\"0fd0d80\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-b7cc1d8 elementor-widget elementor-widget-text-editor\" data-id=\"b7cc1d8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>The platform works directly with the <strong>Teraxium Oncology<\/strong>platform for digital oncology therapies. It can be used by patients undergoing cancer treatments such as:<\/p><ul><li>Chemotherapies<\/li><li>Immunotherapies<\/li><li>Digital Therapies<\/li><\/ul><p>The result of the information provided by the application goes according to the symptoms that the user records, adapts to offer personalized guidance on how he can self-control his condition and how to handle his symptoms and instructions on how and when to take the supportive therapies included in his care plan.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-9e6f507\" data-id=\"9e6f507\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8c9da01 elementor-widget elementor-widget-image\" data-id=\"8c9da01\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"1200\" height=\"630\" src=\"https:\/\/saluddigital.com\/wp-content\/uploads\/2020\/06\/Oleena.png\" class=\"attachment-full size-full wp-image-8227\" alt=\"\" srcset=\"https:\/\/saluddigital.com\/wp-content\/uploads\/2020\/06\/Oleena.png 1200w, https:\/\/saluddigital.com\/wp-content\/uploads\/2020\/06\/Oleena-660x347.png 660w, https:\/\/saluddigital.com\/wp-content\/uploads\/2020\/06\/Oleena-768x403.png 768w, https:\/\/saluddigital.com\/wp-content\/uploads\/2020\/06\/Oleena-840x441.png 840w\" sizes=\"(max-width: 1200px) 100vw, 1200px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-e677ec1 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-equal-height-no\" data-id=\"e677ec1\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-42cc5cc\" data-id=\"42cc5cc\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-56466ac elementor-widget elementor-widget-text-editor\" data-id=\"56466ac\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>\"Beyond controlling their symptoms, we believe that empowering patients through digital delivery of personalized, real-time therapeutic interventions offers the opportunity to achieve meaningful clinical and economic results,\" Pierre Leurent, CEO of Voluntis, said in a statement. \"We are delighted to present Oleena, the first digital therapeutic prescription in oncology, to transform the patient experience throughout their cancer journey.\"<\/p><p>The main impact of this software is to allow patients to play a more active role in their care and control serious symptoms that can complicate treatment. As for the provider, their focus is on improving monitoring through an interface that highlights cases that need more attention and benefit the patient care team.<\/p><p>\"Digital therapeutics like Oleena represent a critical addition to managing symptoms at the level of oncology practices,\" Dr. Arvind Dasari of the University of Texas MD Anderson Cancer Center said in a statement provided by Voluntis. \"Simple language and easy-to-use interfaces simplify patient self-management. Integrated clinical algorithms enable automated, proactive intervention that helps healthcare teams, both in terms of customization and standardization.\"<\/p><p>Oleena's algorithms completely rethink users' experience of information obtained through applications to understand and be able to better track treatments to fight cancer.<\/p><p>The use of Oleena is only allowed with a prescription, but there are other tools focused on monitoring the symptoms of cancer patients who have free use.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-cbfa32b elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-equal-height-no\" data-id=\"cbfa32b\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-cd1fe7e\" data-id=\"cd1fe7e\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-d21cb23 elementor-widget elementor-widget-toggle\" data-id=\"d21cb23\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"toggle.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-toggle\">\n\t\t\t\t\t\t\t<div class=\"elementor-toggle-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-2201\" class=\"elementor-tab-title\" data-tab=\"1\" role=\"button\" aria-controls=\"elementor-tab-content-2201\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon elementor-toggle-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-closed\"><i class=\"fas fa-caret-right\"><\/i><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-toggle-icon-opened\"><i class=\"elementor-toggle-icon-opened fas fa-caret-up\"><\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-toggle-title\" tabindex=\"0\">BIBLIOGRAPHY<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t<div id=\"elementor-tab-content-2201\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"1\" role=\"region\" aria-labelledby=\"elementor-tab-title-2201\"><p><strong>MOBI HEALTH NEWS<\/strong><\/p><p><a href=\"https:\/\/www.mobihealthnews.com\/news\/voluntis-symptom-management-platform-cancer-patients-receives-fdas-blessing?mkt_tok=eyJpIjoiWWpSaE1qRmlORGRqTURNMyIsInQiOiJIakNMS0tTajlaWk5xdytGRGJPZHRVZHR4cFlKMnROZmRmSVU3TzJTYVBuV1wvQ2tNSWwwYitXdEh2SFwvOFRzXC9nMm5ESXJDSHRqZHVHaFwvMDJCWEc0S2U4TXdmellSaTVXVWVCWTc5WE9ROVRxaDY0RVwvcldLbHlwempSdXZHWUVTIn0%3D\">https:\/\/www.mobihealthnews.com\/news\/voluntis-symptom-management-platform-cancer-patients-receives-fdas-blessing?mkt_tok=eyJpIjoiWWpSaE1qRmlORGRqTURNMyIsInQiOiJIakNMS0tTajlaWk5xdytGRGJPZHRVZHR4cFlKMnROZmRmSVU3TzJTYVBuV1wvQ2tNSWwwYitXdEh2SFwvOFRzXC9nMm5ESXJDSHRqZHVHaFwvMDJCWEc0S2U4TXdmellSaTVXVWVCWTc5WE9ROVRxaDY0RVwvcldLbHlwempSdXZHWUVTIn0%3D<\/a><\/p><p>\u00a0<\/p><p><strong>VOLUNTIS<\/strong><\/p><p>\u00a0<\/p><p><a href=\"http:\/\/voluntis.com\/en\/news\/news-1\/2019\/voluntis-announces-market-authorization-for-oleena-first-digital-therapeutic-in-oncology\">http:\/\/voluntis.com\/en\/news\/news-1\/2019\/voluntis-announces-market-authorization-for-oleena-first-digital-therapeutic-in-oncology<\/a><\/p><p>\u00a0<\/p><p><strong>ABOUT FDA AND CLASS DEVICES<\/strong><\/p><p><a href=\"https:\/\/sites.jamanetwork.com\/spanish-patient-pages\/2014\/hoja-para-el-paciente-de-jama-140122.pdf\">https:\/\/sites.jamanetwork.com\/spanish-patient-pages\/2014\/hoja-para-el-paciente-de-jama-140122.pdf<\/a><\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>La plataforma patentada por Voluntis trabajar\u00e1 con algoritmos que, basados en la informaci\u00f3n de los usuarios, ofrecer\u00e1n orientaci\u00f3n personalizada sobre los s\u00edntomas del c\u00e1ncer y c\u00f3mo mitigarlos. Adem\u00e1s, podr\u00e1n los equipos t\u00e9cnicos monitorear y generar mayor informaci\u00f3n respecto al estado del paciente. La Administraci\u00f3n de Alimentos y Medicamentos (FDA, por sus siglas en ingl\u00e9s), ha aprobado la plataforma Oleena que, basada en algoritmos y con la experiencia del usuario, ofrecer\u00e1 una din\u00e1mica personalizada para el paciente, as\u00ed como el monitoreo y generaci\u00f3n de informaci\u00f3n para los Profesionales de la Salud. Oleena es un software que forma parte de los dispositivos de Clase II, esto quiere decir que son de riesgo medio y no utilizan sustancias m\u00e9dicas para generar un diagn\u00f3stico con el paciente. La plataforma trabaja directamente con la plataforma Teraxium Oncology, para terapias de oncolog\u00eda digital. Puede ser utilizado por pacientes sometidos a tratamientos de c\u00e1ncer como: Quimioterapias Inmunoterapias Terapias digitales El resultado de la informaci\u00f3n que provee la aplicaci\u00f3n va de acuerdo con los s\u00edntomas que el usuario registra, se adapta para ofrecer orientaci\u00f3n personalizada sobre c\u00f3mo puede auto controlar su condici\u00f3n y c\u00f3mo manejar sus sintomatolog\u00edas e instrucciones sobre c\u00f3mo y cu\u00e1ndo tomar las terapias de apoyo incluidas en su plan de atenci\u00f3n. &#8220;M\u00e1s all\u00e1 de controlar sus s\u00edntomas, creemos que empoderar a los pacientes a trav\u00e9s de la entrega digital de intervenciones terap\u00e9uticas personalizadas y en tiempo real ofrece la oportunidad de obtener resultados cl\u00ednicos y econ\u00f3micos significativos&#8221;, dijo Pierre Leurent, CEO de Voluntis, en un comunicado. &#8220;Estamos encantados de presentar Oleena, la primera prescripci\u00f3n terap\u00e9utica digital en oncolog\u00eda, para transformar la experiencia de los pacientes a lo largo de su viaje por el c\u00e1ncer&#8221;. El principal impacto de este software es permitir a los pacientes tener un papel m\u00e1s activo en su cuidado y controlar los s\u00edntomas graves que pueden complicar el tratamiento. En cuanto al proveedor, su enfoque est\u00e1 en mejorar el monitoreo a trav\u00e9s de una interfaz que resalta los casos que necesitan m\u00e1s atenci\u00f3n y beneficiar al equipo encargado del cuidado del paciente. &#8220;La terap\u00e9utica digital como Oleena representa una adici\u00f3n de importancia cr\u00edtica al manejo de los s\u00edntomas a nivel de pr\u00e1cticas oncol\u00f3gicas&#8221;, dijo el Dr. Arvind Dasari del MD Anderson Cancer Center de la Universidad de Texas en un comunicado proporcionado por Voluntis. \u201cEl lenguaje sencillo y las interfaces f\u00e1ciles de usar simplifican la autogesti\u00f3n del paciente. Los algoritmos cl\u00ednicos integrados permiten una intervenci\u00f3n automatizada y proactiva que ayuda a los equipos de atenci\u00f3n m\u00e9dica, tanto en t\u00e9rminos de personalizaci\u00f3n como de estandarizaci\u00f3n&#8221;. Los algoritmos de Oleena replantean completamente la experiencia de los usuarios en cuanto a la informaci\u00f3n obtenida por medio de aplicaciones en pro de entender y poder llevar de mejor manera el seguimiento a los tratamientos para combatir el c\u00e1ncer. El uso de Oleena es solamente permitido con receta m\u00e9dica, pero existen otro tipo de herramientas enfocadas en monitorear los s\u00edntomas de pacientes con c\u00e1ncer que tienen uso libre. BIBLIOGRAF\u00cdA MOBI HEALTH NEWS https:\/\/www.mobihealthnews.com\/news\/voluntis-symptom-management-platform-cancer-patients-receives-fdas-blessing?mkt_tok=eyJpIjoiWWpSaE1qRmlORGRqTURNMyIsInQiOiJIakNMS0tTajlaWk5xdytGRGJPZHRVZHR4cFlKMnROZmRmSVU3TzJTYVBuV1wvQ2tNSWwwYitXdEh2SFwvOFRzXC9nMm5ESXJDSHRqZHVHaFwvMDJCWEc0S2U4TXdmellSaTVXVWVCWTc5WE9ROVRxaDY0RVwvcldLbHlwempSdXZHWUVTIn0%3D \u00a0 VOLUNTIS \u00a0 http:\/\/voluntis.com\/en\/news\/news-1\/2019\/voluntis-announces-market-authorization-for-oleena-first-digital-therapeutic-in-oncology \u00a0 SOBRE FDA Y DISPOSITIVOS DE CLASE https:\/\/sites.jamanetwork.com\/spanish-patient-pages\/2014\/hoja-para-el-paciente-de-jama-140122.pdf<\/p>","protected":false},"author":1,"featured_media":8227,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[156,153],"tags":[145],"class_list":["post-8226","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-big-data","category-plataformas-digitales","tag-noticias"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/posts\/8226","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/comments?post=8226"}],"version-history":[{"count":0,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/posts\/8226\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/media\/8227"}],"wp:attachment":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/media?parent=8226"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/categories?post=8226"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/tags?post=8226"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}